中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝昏迷患者经人工肝治疗后成功行跨血型肝移植1例报告

孙爽 刘金泉 冯帅 王淑贤 徐祥美 戴德淑 王建红 蔡金贞 许传屾

引用本文:
Citation:

肝昏迷患者经人工肝治疗后成功行跨血型肝移植1例报告

DOI: 10.12449/JCH240423
基金项目: 

山东省自然科学基金面上项目 (ZR2023MH240);

北京肝胆相照公益基金会“2023年度人工肝专项基金” (iGandanF-1082023-RGG037);

青岛大学附属医院“临床医学+X”科研项目 (QYFY+X202101060)

伦理学声明:本例报告已获得患者知情同意。
利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:孙爽负责课题设计,资料分析,撰写论文;刘金泉、冯帅、王淑贤、徐祥美、戴德淑负责课题设计;王建红、蔡金贞负责拟定写作思路;许传屾负责指导撰写文章并最后定稿。
详细信息
    通信作者:

    许传屾, xcs774279@163.com (ORCID: 0009-0004-0770-6409)

Successful trans-blood liver transplantation after artificial liver support therapy in a patient with hepatic coma: A case report

Research funding: 

General Project of Shandong Natural Science Foundation (ZR2023MH240);

The “2023 Artificial Liver Special Fund” of the Beijing Hepatobiliary Mutual Welfare Foundation (iGandanF-1082023-RGG037);

The “Clinical Medicine+X” Research Project of Qingdao University Affiliated Hospital (QYFY+X202101060)

More Information
    Corresponding author: XU Chuanshen, xcs774279@163.com (ORCID: 0009-0004-0770-6409)
  • 摘要: 本文报告1例经过人工肝支持治疗并成功过渡到肝移植的肝昏迷患者,经过积极治疗后患者后期恢复较好。并且对肝移植手术的时机进行了讨论。

     

  • 图  1  经过人工肝治疗后患者血氨、总胆红素、转氨酶的变化情况

    注: 红色箭头提示行非生物型人工肝的时机。

    Figure  1.  Changes in blood ammonia, total bilirubin, and transaminase in patients after artificial liver treatment

    图  2  手术切下的病肝

    Figure  2.  Photos of diseased liver

    图  3  移植后的新肝

    Figure  3.  Photos of new liver

  • [1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.

    中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
    [2] WU CB, ZHOU MX, MENG Y, et al. Application and research progress of non-bioartificial liver[J]. Biomed Eng Clin Med, 2021, 25( 5): 634- 638. DOI: 10.13339/j.cnki.sglc.20210820.009.

    吴春波, 周明雪, 孟彦, 等. 非生物型人工肝的应用及研究进展[J]. 生物医学工程与临床, 2021, 25( 5): 634- 638. DOI: 10.13339/j.cnki.sglc.20210820.009.
    [3] CHEN MJ, LI X, TANG SH. Advances in multi-dimensional assessment of liver function in the prognosis of patients with liver failure[J]. Clin J Med Offic, 2023, 51( 9): 901- 903, 907. DOI: 10.16680/j.1671-3826.2023.09.05.

    陈美娟, 李雪, 汤善宏. 多维度评估肝功能在肝衰竭患者预后中研究进展[J]. 临床军医杂志, 2023, 51( 9): 901- 903, 907. DOI: 10.16680/j.1671-3826.2023.09.05.
    [4] ARTRU F, LOUVET A, RUIZ I, et al. Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3[J]. J Hepatol, 2017, 67( 4): 708- 715. DOI: 10.1016/j.jhep.2017.06.009.
    [5] KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33( 2): 464- 470. DOI: 10.1053/jhep.2001.22172.
    [6] MARTIN P, DIMARTINI A, FENG S, et al. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation[J]. Hepatology, 2014, 59( 3): 1144- 1165. DOI: 10.1002/hep.26972.
    [7] European Association for the Study of the Liver. EASL clinical practice guidelines: Liver transplantation[J]. J Hepatol, 2016, 64( 2): 433- 485. DOI: 10.1016/j.jhep.2015.10.006.
    [8] Hepatology Branch of the Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35( 11): 2408- 2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.

    中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35( 11): 2408- 2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
    [9] Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of hepatic encephalopathy in cirrhosis[J]. J Clin Hepatol, 2018, 34( 10): 2076- 2089. DOI: 10.3969/j.issn.1001-5256.2018.10.007.

    中华医学会肝病学分会. 肝硬化肝性脑病诊疗指南[J]. 临床肝胆病杂志, 2018, 34( 10): 2076- 2089. DOI: 10.3969/j.issn.1001-5256.2018.10.007.
    [10] Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol, 2017, 33( 10): 1847- 1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.

    中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 临床肝胆病杂志, 2017, 33( 10): 1847- 1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.
    [11] European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69( 2): 406- 460. DOI: 10.1016/j.jhep.2018.03.024.
    [12] BOYER TD, SANYAL AJ, GARCIA-TSAO G, et al. Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1[J]. Liver Transpl, 2011, 17( 11): 1328- 1332. DOI: 10.1002/lt.22395.
  • 加载中
图(3)
计量
  • 文章访问数:  260
  • HTML全文浏览量:  159
  • PDF下载量:  40
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-07-19
  • 录用日期:  2023-09-18
  • 出版日期:  2024-04-25
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回